Attached files

file filename
EX-31.1 - EX-31.1 - Cue Biopharma, Inc.d923493dex311.htm
10-K/A - 10-K/A - Cue Biopharma, Inc.d923493d10ka.htm

Exhibit 31.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Kerri-Ann Millar, certify that:

 

1.

I have reviewed this Amendment No. 2 to Annual Report on Form 10-K of Cue Biopharma, Inc.; and

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

Date: April 29, 2020

 

  Cue Biopharma, Inc.

          By:  

/s/ Kerri-Ann Millar

 

Kerri-Ann Millar

Vice President, Finance

(Principal Financial Officer and Principal Accounting Officer)